Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Going for Growth? Consider a Concentrated Approach

BY | ETF Database
10:53 am ET 06/09/26 | 9 VIEWS
Broadly speaking, it’s fair to say that 2026 has not played out the way that most advisors and investors expected it to. Geopolitical conflicts have arisen, gas prices remain rocky, and some worry inflation could be making a comeback.However, all of these uncertainties have been juxtaposed with strong corporate earnings growth. Even in a period of relative volatility, many tried-and-tested large-cap companies continue to post compelling earnings results. For example, chipmaking titan Nvidia’s Q1 2027 results showcased revenue of $ 81 billion, representing an 85% jump from last year’s report. Meanwhile, data center revenue came in at $75.2%, up 92% from Q1 2026. See more: BNY Flagship Infrastructure ETF BKGI Hits $1 Billion in AUM Crucially, it’s not just the tech companies that are seeing standout performances as of late. In Eli Lilly’s Q1 2026 earnings report, the pharmaceutical giant reported revenue of $19.8 billion, roundly outpacing analyst expectations and coming in 52% higher than last year’s report. This is the dynamic that advisors and investors are currently trying to navigate — companies doing extremely well, but the macroeconomic environment itself may become more unstable down the line. So how should one go about building exposure to crucial areas like the U.S. large-cap market? One way to do so is through a concentrated approach. By investing in a more concentrated, actively managed portfolio, advisors and investors can potentially access the strongest available companies while trimming away the ones that would otherwise lag behind.BKCG Offers Easy Access to Concentrated Large-Cap ExposureA fund that could certainly offer a use case for this very purpose is the BNY Mellon Concentrated Growth ETF (BKCG ). Actively managed, BKCG provides disciplined buy-and-hold exposure to a specific selection of growth companies. The portfolio’s core holdings include market leaders like Nvidia and Eli Lilly, as of June 2, 2026, See more: The ETF Evolution: How a 1993 Idea Changed Investing BKCG’s portfolio team focuses on sectors poised for growth over the next three to five years, or even longer. From there, the fund applies fundamental analysis to select market-leading companies within these sectors — prioritizing those with strong balance sheets, expanding global presences, and competitive advantages. Reflecting its growth-driven mandate, BKCG has seen significant results across the last year. As of May 31, 2026, the fund’s NAV has risen 17.05% over the past 12 months. For more news, information, and analysis, visit our Portfolio Strategies Content Hub.

More Commentary

Fees Matter: The Power of Passive ETFs
BY | ETF Database
6:40 am ET 06/09/26 | 50 VIEWS
Bottom of the Stack: ETFs Fueling the AI Power Play
BY | ETF Database
9:25 am ET 06/09/26 | 27 VIEWS
Week of June 1’s Top Stories Covered SpaceX IPO, First Autism ETF
BY | ETF Database
12:58 pm ET 06/09/26 | 0 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.